Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $156.64 | 10 | 88.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20.00 | 1 | 11.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $93.94 | 6 | $0 (2024) |
| Allergan Inc. | $44.27 | 2 | $0 (2017) |
| Avanos Medical | $13.84 | 1 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $12.44 | 1 | $0 (2018) |
| Synergy Pharmaceuticals Inc | $12.15 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20.00 | 1 | ABBVIE INC. ($20.00) |
| 2021 | $13.84 | 1 | Avanos Medical ($13.84) |
| 2018 | $41.00 | 3 | AbbVie, Inc. ($28.56) |
| 2017 | $101.80 | 6 | AbbVie, Inc. ($45.38) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | CREON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $20.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/02/2021 | Avanos Medical | INITIAL PLACEMENT KITS (Device) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: DIGESTIVE HEALTH | ||||||
| 08/08/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Immunology | ||||||
| 05/04/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Immunology | ||||||
| 05/03/2018 | Merck Sharp & Dohme Corporation | RENFLEXIS (Biological) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: IMMUNOLOGY | ||||||
| 12/14/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Immunology | ||||||
| 11/06/2017 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/16/2017 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: Virology | ||||||
| 09/08/2017 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/10/2017 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: Gastroenterology | ||||||
| 05/03/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 586 | 614 | $211,857 | $50,446 |
| 2022 | 13 | 617 | 688 | $205,874 | $56,475 |
| 2021 | 15 | 720 | 815 | $204,779 | $58,810 |
| 2020 | 17 | 841 | 1,962 | $363,275 | $105,811 |
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 56 | 56 | $53,028 | $10,637 | 20.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 93 | $17,325 | $8,402 | 48.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 37 | 37 | $29,595 | $6,334 | 21.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 44 | 44 | $13,420 | $5,576 | 41.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $10,350 | $4,286 | 41.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 57 | 71 | $8,290 | $4,276 | 51.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 54 | 54 | $33,480 | $4,186 | 12.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 22 | 22 | $17,210 | $2,339 | 13.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 11 | 11 | $7,427 | $1,912 | 25.7% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 11 | 11 | $7,700 | $1,056 | 13.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 13 | $1,715 | $796.88 | 46.5% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 149 | 149 | $12,208 | $552.02 | 4.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 11 | 11 | $110.00 | $92.40 | 84.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 116 | 144 | $26,640 | $13,254 | 49.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 58 | 58 | $55,119 | $11,479 | 20.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 58 | 58 | $14,210 | $6,629 | 46.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 40 | 40 | $12,200 | $5,982 | 49.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 32 | 32 | $23,018 | $5,812 | 25.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 58 | 90 | $10,350 | $5,031 | 48.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 43 | 43 | $26,660 | $3,209 | 12.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 19 | 19 | $15,670 | $1,688 | 10.8% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 12 | 12 | $8,400 | $1,371 | 16.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 17 | $2,210 | $983.97 | 44.5% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 128 | 129 | $10,413 | $485.98 | 4.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 21 | 21 | $735.00 | $475.44 | 64.7% |
About Dr. John Buhac, MD
Dr. John Buhac, MD is a Gastroenterology healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235184789.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Buhac, MD has received a total of $176.64 in payments from pharmaceutical and medical device companies, with $20.00 received in 2024. These payments were reported across 11 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($156.64).
As a Medicare-enrolled provider, Buhac has provided services to 2,764 Medicare beneficiaries, totaling 4,079 services with total Medicare billing of $271,542. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Albany, NY
- Active Since 05/23/2006
- Last Updated 01/06/2016
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1235184789
Products in Payments
- Humira (Biological) $62.44
- VIBERZI (Drug) $44.27
- CREON (Drug) $20.00
- INITIAL PLACEMENT KITS (Device) $13.84
- RENFLEXIS (Biological) $12.44
- Trulance (Drug) $12.15
- Mavyret (Drug) $11.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Albany
Bora Gumustop, M.d, M.D
Gastroenterology — Payments: $106,464
Dr. Robert Gianotti, Md, MD
Gastroenterology — Payments: $57,850
Mandeep Bhamra, M.d, M.D
Gastroenterology — Payments: $44,830
Dr. Jeffrey Gerson, Md, MD
Gastroenterology — Payments: $32,008
Joseph Polito, M.d, M.D
Gastroenterology — Payments: $8,726
Dr. Seth Richter, M.d, M.D
Gastroenterology — Payments: $7,843